JPMorgan Chase & Co. Raises Waters (NYSE:WAT) Price Target to $325.00

Key Points

• JPMorgan Chase & Co. has raised the price target for Waters from $300.00 to $325.00, maintaining a "neutral" rating on the stock.
• Other analysts have differing views on Waters, with Rothschild Redburn upgrading it to a "strong-buy" and setting a price target of $390.00.
• Waters reported a quarterly EPS of $2.95, exceeding expectations, and had revenue of $771.33 million for the quarter, marking an 8.8% year-over-year increase.

Waters (NYSE:WAT - Get Free Report) had its price target boosted by JPMorgan Chase & Co. from $300.00 to $325.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm currently has a "neutral" rating on the medical instruments supplier's stock. JPMorgan Chase & Co.'s price objective would indicate a potential downside of 0.83% from the stock's previous close.

Other equities research analysts have also recently issued research reports about the stock. Rothschild Redb raised shares of Waters to a "strong-buy" rating in a research note on Wednesday. Rothschild & Co Redburn began coverage on shares of Waters in a report on Wednesday. They set a "buy" rating and a $390.00 price target for the company. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Waters and gave the company a "hold" rating in a report on Tuesday, August 5th. UBS Group reiterated a "neutral" rating on shares of Waters in a report on Tuesday, July 15th. Finally, Bank of America upped their price target on shares of Waters from $370.00 to $375.00 and gave the company a "neutral" rating in a report on Thursday, June 26th. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $377.56.

Waters Trading Up 0.0%

Shares of Waters stock traded up $0.06 during trading on Thursday, reaching $327.71. The company's stock had a trading volume of 15,914 shares, compared to its average volume of 622,407. Waters has a 52-week low of $275.05 and a 52-week high of $423.56. The company has a market cap of $19.51 billion, a price-to-earnings ratio of 29.55, a PEG ratio of 2.97 and a beta of 1.04. The firm's 50-day moving average is $298.31 and its two-hundred day moving average is $324.73. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The company had revenue of $771.33 million during the quarter, compared to analysts' expectations of $745.96 million. During the same quarter in the prior year, the company earned $2.63 EPS. The firm's revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, sell-side analysts anticipate that Waters will post 12.86 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in WAT. Olde Wealth Management LLC purchased a new stake in shares of Waters in the 1st quarter worth about $25,000. Zions Bancorporation National Association UT purchased a new stake in shares of Waters in the 1st quarter worth about $28,000. IFP Advisors Inc grew its position in shares of Waters by 118.9% in the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after buying an additional 44 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Waters in the 1st quarter worth about $41,000. Finally, CYBER HORNET ETFs LLC purchased a new stake in shares of Waters in the 2nd quarter worth about $53,000. 94.01% of the stock is currently owned by institutional investors.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.